CN111627506A - Lung cancer patient follow-up system - Google Patents
Lung cancer patient follow-up system Download PDFInfo
- Publication number
- CN111627506A CN111627506A CN202010437517.2A CN202010437517A CN111627506A CN 111627506 A CN111627506 A CN 111627506A CN 202010437517 A CN202010437517 A CN 202010437517A CN 111627506 A CN111627506 A CN 111627506A
- Authority
- CN
- China
- Prior art keywords
- module
- information
- recording
- follow
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010058467 Lung neoplasm malignant Diseases 0.000 title claims abstract description 40
- 201000005202 lung cancer Diseases 0.000 title claims abstract description 40
- 208000020816 lung neoplasm Diseases 0.000 title claims abstract description 40
- 230000001575 pathological effect Effects 0.000 claims abstract description 28
- 210000001165 lymph node Anatomy 0.000 claims abstract description 20
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 18
- 239000000439 tumor marker Substances 0.000 claims abstract description 15
- 238000001514 detection method Methods 0.000 claims abstract description 14
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 11
- 230000009325 pulmonary function Effects 0.000 claims abstract description 8
- 230000000391 smoking effect Effects 0.000 claims abstract description 6
- 230000001394 metastastic effect Effects 0.000 claims abstract description 5
- 206010061289 metastatic neoplasm Diseases 0.000 claims abstract description 5
- 238000001914 filtration Methods 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 2
- 238000010586 diagram Methods 0.000 description 25
- 210000004072 lung Anatomy 0.000 description 8
- 238000003745 diagnosis Methods 0.000 description 7
- 230000003902 lesion Effects 0.000 description 6
- 230000004199 lung function Effects 0.000 description 6
- 230000007170 pathology Effects 0.000 description 5
- 210000003437 trachea Anatomy 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 102000012406 Carcinoembryonic Antigen Human genes 0.000 description 2
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 2
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000005015 mediastinal lymph node Anatomy 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 102000006601 Thymidine Kinase Human genes 0.000 description 1
- 108020004440 Thymidine kinase Proteins 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 201000008395 adenosquamous carcinoma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002458 carcinoid tumor Diseases 0.000 description 1
- 238000013132 cardiothoracic surgery Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 208000003849 large cell carcinoma Diseases 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 108010067654 nerveside Proteins 0.000 description 1
- 238000002638 palliative care Methods 0.000 description 1
- 210000003105 phrenic nerve Anatomy 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 208000014212 sarcomatoid carcinoma Diseases 0.000 description 1
- 208000000649 small cell carcinoma Diseases 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 206010055031 vascular neoplasm Diseases 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Public Health (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
The application provides a lung cancer patient follow-up visit system, which comprises a patient information input module, a follow-up visit module and a follow-up visit module, wherein the patient information input module is used for inputting basic information of a patient; the contact information input module is used for inputting contact information of the patient; the hospital mark input module is used for inputting a medical record number, a hospital bed number and an attending doctor; the medical history and life history recording module is used for recording smoking history, tumor history and operation history; the cancer marker recording module is used for recording cancer marker information; the pulmonary function recording module is used for recording pulmonary function information; the pathological result input module is used for inputting lung cancer pathological information; the lymph node group number recording module is used for recording the range information of the metastatic lymph nodes; the pathological staging recording module is used for recording pathological staging information; the gene detection input module is used for inputting gene detection information; the treatment scheme recording module is used for recording treatment scheme information; the follow-up recording module is used for recording follow-up information in the treatment process; and the storage module is used for storing the information recorded by each module.
Description
Technical Field
The application relates to the technical field of lung cancer patient information management, in particular to a lung cancer patient follow-up system.
Background
After the lung cancer patient is diagnosed, the lung cancer patient needs to be diagnosed and treated for a long time. In the diagnosis and treatment process, a follow-up system is often established in order to record and conveniently manage the diagnosis and treatment information of the patient. However, when the existing follow-up system records the patient information, the operation is inconvenient, the recorded information is not comprehensive and accurate enough, and the efficient management of the patient information is not facilitated.
Disclosure of Invention
The application aims to provide a lung cancer patient follow-up system for realizing the technical effect of managing the information of patients more comprehensively and accurately.
The embodiment of the application provides a lung cancer patient follow-up visit system, which comprises a patient information input module, a follow-up visit module and a follow-up visit module, wherein the patient information input module is used for inputting basic information of a patient; the contact information input module is used for inputting contact information of the patient; the hospital mark input module is used for inputting a medical record number, a hospital bed number and an attending doctor; the medical history and life history recording module is used for recording smoking history, tumor history and operation history; the cancer marker recording module is used for recording cancer marker information; the pulmonary function recording module is used for recording pulmonary function information; the pathological result input module is used for inputting lung cancer pathological information; the lymph node group number recording module is used for recording the range information of the metastatic lymph nodes; the pathological staging recording module is used for recording pathological staging information; the gene detection input module is used for inputting gene detection information; the treatment scheme recording module is used for recording treatment scheme information; the follow-up recording module is used for recording follow-up information in the treatment process; and the storage module is used for storing the information recorded by each module.
Furthermore, the lung cancer patient follow-up system also comprises an inquiry module, wherein the inquiry module is used for searching the information of the target patient recorded in the system according to the name or the identification number of the target patient.
Further, the lung cancer patient follow-up system further comprises an information display module for displaying the information of the target patient inquired by the inquiry module.
Further, the lung cancer patient follow-up system further comprises a display layout setting module for setting display parameters of the information display module, wherein the display parameters comprise the number of display lines and the number of columns of the information display module.
Further, the lung cancer patient follow-up system further comprises a first positioning module; the positioning module is used for positioning the row of the display target module.
Further, the follow-up entry module comprises a second positioning module for highlighting the selected follow-up record information.
Further, the lung cancer patient follow-up system further comprises a filtering display module for screening the information of the target patient to be displayed.
Furthermore, the lung cancer patient follow-up system also comprises a statistical module for counting the proportion of male and female patients in the system and the number of newly-added patients per month.
Further, the lung cancer patient follow-up system further comprises a login module used for providing login and registration service for the user.
The beneficial effect that this application can realize is: through the patient information input module, the contact mode input module, the hospital mark input module, the medical history and life history input module, the cancer marker input module, the lung function input module, the pathological result input module, the lymph node group number input module, the pathological stage input module, the gene detection input module, the treatment scheme input module, the follow-up visit input module and the storage module which are arranged in the system, the relevant information of the diagnosis and treatment process of a patient can be comprehensively recorded, and meanwhile, each module is independently arranged, so that the diagnosis and treatment information of the patient can be more conveniently and accurately input.
Drawings
In order to more clearly illustrate the technical solutions of the embodiments of the present application, the drawings that are required to be used in the embodiments of the present application will be briefly described below, it should be understood that the following drawings only illustrate some embodiments of the present application and therefore should not be considered as limiting the scope, and that those skilled in the art can also obtain other related drawings based on the drawings without inventive efforts.
Fig. 1 is a schematic topology diagram of a lung cancer patient follow-up system according to an embodiment of the present disclosure;
FIG. 2 is a schematic structural diagram of a patient information entry module according to an embodiment of the present disclosure;
fig. 3 is a schematic structural diagram of a contact type entry module according to an embodiment of the present disclosure;
FIG. 4 is a schematic diagram of a hospital internal standard registration module according to an embodiment of the present disclosure;
FIG. 5 is a block diagram illustrating a medical history and life history recording module according to an embodiment of the present disclosure;
FIG. 6 is a schematic structural diagram of a cancer marker entry module provided in an embodiment of the present application;
fig. 7 is a schematic structural diagram of a lung function entry module according to an embodiment of the present application;
fig. 8 is a schematic structural diagram of a pathological result entry module provided in the embodiment of the present application;
fig. 9 is a schematic structural diagram of a lymph node group number entry module provided in an embodiment of the present application;
fig. 10 is a schematic structural diagram of a pathology staging module provided in an embodiment of the present application;
FIG. 11 is a schematic structural diagram of a gene detection entry module provided in an embodiment of the present application;
FIG. 12 is a schematic structural diagram of a treatment protocol entry module provided in an embodiment of the present application;
fig. 13 is a schematic structural diagram of a follow-up entry module according to an embodiment of the present application;
fig. 14 is a schematic view of a display mode according to an embodiment of the present application.
Icon: 100-lung cancer patient follow-up system; 110-patient information entry module; 120-a query module; 130-contact information input module; 140-yard mark input module; 150-medical history and life history recording module; 160-cancer marker entry module; 170-lung function entry module; 180-pathological result input module; 190-lymph node group number recording module; 200-pathological staging recording module; 210-gene detection input module; 220-treatment protocol entry module; 230-follow-up recording module; 231-a second positioning module; 240-display layout setting module; 250-a storage module; 260-login module; 270-an information display module; 280-a first positioning module; 290-a filtering display module; 300-a statistical module.
Detailed Description
The technical solutions in the embodiments of the present application will be described below with reference to the drawings in the embodiments of the present application.
It should be noted that: like reference numbers and letters refer to like items in the following figures, and thus, once an item is defined in one figure, it need not be further defined and explained in subsequent figures. Meanwhile, in the description of the present application, the terms "first", "second", and the like are used only for distinguishing the description, and are not to be construed as indicating or implying relative importance.
Referring to fig. 1, fig. 1 is a schematic view of a topology structure of a lung cancer patient follow-up system according to an embodiment of the present application.
The lung cancer patient follow-up system 100 provided by the embodiment of the application comprises a patient information entry module 110, which is used for entering basic information of a patient; a contact information input module 130 for inputting the contact information of the patient; the hospital mark recording module 140 is used for recording a medical record number, a hospital bed number and an attending doctor; a medical history and life history recording module 150 for recording smoking history, tumor history and operation history; a cancer marker entry module 160 for entering cancer marker information; a lung function recording module 170 for recording lung function information; a pathological result input module 180 for inputting lung cancer pathological information; a lymph node group number recording module 190 for recording the range information of the metastatic lymph nodes; a pathology staging recording module 200 for recording pathology staging information; the gene detection input module 210 is used for inputting gene detection information; a treatment plan entry module 220 for entering treatment plan information; a follow-up recording module 230, configured to record follow-up information in a treatment process; and the storage module 250 is used for storing the information recorded by each module.
Referring to fig. 2, fig. 2 is a schematic structural diagram of a patient information entry module according to an embodiment of the present application.
As shown in fig. 2, in one embodiment, the patient information entry module 110 may enter information such as the identification number, name, sex, age, weight, and height of the patient, click to submit after all the information is entered, and the storage module 250 may input the submitted information into the memory for storage.
Please refer to fig. 3, fig. 3 is a schematic structural diagram of a contact type entry module according to an embodiment of the present application.
As shown in FIG. 3, in one embodiment, the contact information entry module 130 may enter information such as the name, relationship with the patient, phone number and address of the patient's family members, and the received information is entered into the memory for storage by clicking the post-submission storage module 250.
Referring to fig. 4, fig. 4 is a schematic diagram of a hospital internal standard registration module according to an embodiment of the present application.
As shown in FIG. 4, in one embodiment, the hospital indicia entry module 140 can enter information such as the patient's medical record number, hospital bed number, attending physician, etc. and the received information is entered into the memory for storage by clicking the submit storage module 250.
Please refer to fig. 5, fig. 5 is a schematic structural diagram of a medical history and life history recording module according to an embodiment of the present application.
As shown in FIG. 5, in one embodiment, the medical history and life history recording module 150 can record the smoking history, the tumor history, the duration of the tumor history, the type of the personal operation, the duration of the personal operation, and the like of the patient; the click-to-submit storage module 250 enters the received information into the storage for storage. The history of tumor can be used for filling the information of the existing tumor of the patient, such as gastric cancer, lung cancer, breast cancer, etc. The individual procedure type may fill out which procedures the patient has undergone, such as cardiothoracic surgery.
Referring to fig. 6, fig. 6 is a schematic structural diagram of a cancer marker entry module according to an embodiment of the present application.
As shown in fig. 6, in one embodiment, the cancer marker entry module 160 may fill in the patient's amount of thymidine kinase, carcinoembryonic antigen (CEA), neuron-specific Enolase (NSE), and other cancer markers.
Please refer to fig. 7, fig. 7 is a structural schematic diagram of a lung function entry module according to an embodiment of the present application.
As shown in FIG. 7, in one embodiment, the lung function entry module 170 is configured to enter a ratio of forced end-tidal volume to forced vital capacity for a first second of the patient (i.e., FEV1/FVC, where FEV1 represents the amount of exhalation within 1 second and FVC represents the amount of exhalation lung work).
Please refer to fig. 8, fig. 8 is a schematic structural diagram of a pathological result entry module according to an embodiment of the present application.
As shown in fig. 8, in one embodiment, the pathological result entry module 180 may enter information of pathological description of tumor size (including length, width, height, etc.), tumor maximum diameter, incisal margin distance, pathological description of tumor maximum diameter range, lung pathological histology type, lung origin part, invasion of lung layer thymus, vascular tumor embolism, and the like. The lung histopathology type may be filled in according to the cancer type, for example, according to the following manner: 1. squamous cell carcinoma; 2. small cell carcinoma; 3. adenocarcinoma; 4. large cell carcinoma; 5. adenosquamous carcinoma; 6. sarcomatoid carcinoma; 7. carcinoid; 8 salivary gland type cancer; 9. cancer was not classified.
Please refer to fig. 9, fig. 9 is a schematic structural diagram of a lymph node group number entry module according to an embodiment of the present application.
As shown in fig. 9, in one embodiment, the lymph node group number entry module 190 may enter metastasis range information for the lymph nodes. The content and meaning of the filling are as follows:
1. Lower cervical, supraclavicular and sternal jugular notch lymph nodes
2 area mediastinal lymph node superior area
2R. upper trachea side (right)
2L. side of upper trachea (left)
3a. anterior vascular
3p. behind trachea
4R. lower trachea side (Right)
4L. lower trachea side (left)
3 region aortic lymph node AP region
5. Under aorta
6 aortic side (ascending aorta or phrenic nerve side)
4 area bulge lower area
7. Under the carina
8. Around the esophagus (lower carina)
9. Ligament of inferior lung
6-region N1 lymph node Lung portal/interlobal region
10. Lung door
11. Between leaves
Region around region 7
12. In the leaf
13. In sections
14. In the sub-section
Referring to fig. 10, fig. 10 is a schematic structural diagram of a pathology staging module according to an embodiment of the present application.
As shown in FIG. 10, in one embodiment, the pathology staging module 200 may log pathological staging information (including T stages, N stages, M stages, etc.) for a patient, where T stages represent the size and extent of the primary tumor and N stages represent the condition of the affected lymph nodes; m staging indicates distant metastasis.
Please refer to fig. 11, fig. 11 is a schematic structural diagram of a gene testing entry module according to an embodiment of the present application.
As shown in FIG. 11, in one embodiment, after the patient has performed the genetic test, the genetic test information can be entered into the genetic test entry module 210 in the manner shown in the figure, wherein "+" indicates positive and "-" indicates negative. The main doctor can check the corresponding options according to the gene detection result in the system, and can click and submit the results after confirming the results without errors, and then the results can be stored in the memory through the storage module 250.
Referring to fig. 12, fig. 12 is a schematic structural diagram of a treatment plan entry module according to an embodiment of the present application.
As shown in fig. 12, after confirming the treatment plan, the attending physician of the patient can enter corresponding treatment plan information in the treatment plan entry module 220. After the entry is finished and the confirmation is correct, the user clicks to submit the treatment plan, and the storage module 250 can store the corresponding treatment plan information in the memory.
Specifically, the treatment plan may include various types such as postoperative assistance, radical treatment, palliative treatment, and the like, the configuration information options corresponding to a certain type of treatment plan are displayed below the treatment plan selected by the treating doctor, and the treating doctor can select the corresponding options according to the confirmed treatment plan, click and submit the options, generate a corresponding form, and store the form in the memory through the storage module 250.
Please refer to fig. 13, fig. 13 is a schematic structural diagram of a follow-up entry module according to an embodiment of the present application.
As shown in fig. 13, in one embodiment, after completing a follow-up diagnosis process, a doctor can enter information of follow-up time, follow-up items, main side effects, efficacy evaluation and the like of the follow-up diagnosis in a follow-up entry module 230 in the system. Where cr (complete response) in fig. 13 indicates complete remission of all target lesions disappearance, the minor axis extent of all pathological lymph nodes (whether or not target lesions) must be <10 mm. Pr (partial response) indicates partial remission, with at least a 30% reduction in the sum of target lesion diameters compared to the sum of baseline target lesion diameters. Sd (stable disease) indicates stable disease, less tumor shrinkage than PR criteria and insufficient tumor growth than PD criteria. Pd (progression disease) indicates disease progression with at least a 20% increase in the sum of target lesion diameters (which may include the baseline sum) compared to the smallest sum of target lesion diameters in the study; or an increase in the absolute value of the sum of the diameters of at least 5 mm.
Referring to fig. 14, fig. 14 is a schematic view of a display mode according to an embodiment of the present application.
As shown in FIG. 14, in one embodiment, a query module 120 is also provided in the system; when the name or the identification card of the target patient is inputted into the query module 120 in the system, the information of the target patient recorded in each module can be obtained and then displayed in the information display module 270. When the information display module 270 displays information, the information may be displayed in a manner of displaying 4 modules per line. For ease of reference, a user of the system may also set information such as the number of rows and columns displayed in the display layout setting module 240.
In order to view the information of the required key point more quickly, in one embodiment, a first positioning module 280 is further provided in the system, and the line on which the display target module is located can be positioned by the first positioning module 280.
Specifically, a drop-down menu may be set under each module of the system, and a set-top option is set in each drop-down menu, and when the option is clicked, the row of the target module in the information display module 270 is scrolled to the top of the display area.
Further, in order to query the follow-up records more timely, a second positioning module 231 (i.e., a follow-up record selection menu) may be further disposed in the follow-up entry module 230, and the follow-up records may be added to the menu list or may be selected to be viewed from the stored follow-up records. After the information of the target patient is inputted in the inquiry module 120, in order to more conveniently view the follow-up record information desired to be viewed, the user of the system may highlight the follow-up record information in the information display module 270 after selecting the follow-up record. Specifically, after the user selects the follow-up record, the form corresponding to the follow-up record in the information display module 270 may continuously flash, which is convenient for viewing in time. It should be noted that, in order to highlight the required follow-up record for viewing, the color of the form corresponding to the follow-up record may also be changed; or the form corresponding to the follow-up record is placed in the center of the information display module 270, and the form corresponding to the follow-up record is displayed on the topmost layer.
Further, in consideration of displaying all information of the target patient entered in the system during the query, in order to facilitate the review, the embodiment of the present application further provides a filtering display module 290, and information that is not needed to be reviewed can be filtered through the filtering display module 290. Specifically, a filtering option can be set in a pull-down menu of each module, and when the information of the module does not need to be referred, the option can be clicked to filter the information of the module.
Further, in order to conveniently count the sex distribution of the lung cancer patients and the number of the patients per month, the lung cancer patient follow-up system 100 provided in the embodiment of the present application further includes a counting module 300, and the counting module 300 may display the male-female ratio of the patients recorded in the system through a sector graph, and display the number of the newly added patients per month through a histogram. It should be noted that the display manner of the statistical module 300 is not limited to the above-mentioned manner, and other common display manners may be used.
In an implementation manner, in order to manage the user conveniently, the lung cancer patient follow-up system 10 provided in this embodiment of the present application further includes a login module 260, a new user may register a new account using the login module 260, and the registered user may log in the system using an existing account and a password.
In summary, the embodiment of the present application provides a lung cancer patient follow-up system, which includes a patient information entry module, configured to enter basic information of a patient; the contact information input module is used for inputting contact information of the patient; the hospital mark input module is used for inputting a medical record number, a hospital bed number and an attending doctor; the medical history and life history recording module is used for recording smoking history, tumor history and operation history; the cancer marker recording module is used for recording cancer marker information; the pulmonary function recording module is used for recording pulmonary function information; the pathological result input module is used for inputting lung cancer pathological information; the lymph node group number recording module is used for recording the range information of the metastatic lymph nodes; the pathological staging recording module is used for recording pathological staging information; the gene detection input module is used for inputting gene detection information; the treatment scheme recording module is used for recording treatment scheme information; the follow-up recording module is used for recording follow-up information in the treatment process; and the storage module is used for storing the information recorded by each module. Through the system, the diagnosis and treatment process of the lung cancer patient can be managed more conveniently and efficiently.
The above description is only for the specific embodiments of the present application, but the scope of the present application is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present application, and shall be covered by the scope of the present application. Therefore, the protection scope of the present application shall be subject to the protection scope of the claims.
Claims (9)
1. A lung cancer patient follow-up system, comprising:
the patient information input module is used for inputting basic information of the patient;
the contact information input module is used for inputting contact information of the patient;
the hospital mark input module is used for inputting a medical record number, a hospital bed number and an attending doctor;
the medical history and life history recording module is used for recording smoking history, tumor history and operation history;
the cancer marker recording module is used for recording cancer marker information;
the pulmonary function recording module is used for recording pulmonary function information;
the pathological result input module is used for inputting lung cancer pathological information;
the lymph node group number recording module is used for recording the range information of the metastatic lymph nodes;
the pathological staging recording module is used for recording pathological staging information;
the gene detection input module is used for inputting gene detection information;
the treatment scheme recording module is used for recording treatment scheme information;
the follow-up recording module is used for recording follow-up information in the treatment process;
and the storage module is used for storing the information recorded by each module.
2. The lung cancer patient follow-up system according to claim 1, further comprising a query module for searching for information of a target patient entered in the system according to the name or identification number of the target patient.
3. The lung cancer patient follow-up system according to claim 2, further comprising an information display module for displaying the information of the target patient queried by the query module.
4. The lung cancer patient follow-up system according to claim 2, further comprising a display layout setting module for setting display parameters of the information display module, wherein the display parameters include the number of display rows and the number of display columns of the information display module.
5. The lung cancer patient follow-up system according to claim 2, further comprising a first location module; the first positioning module is used for positioning the row of the display target module.
6. The lung cancer patient follow-up system according to claim 1, wherein the follow-up entry module includes a second location module for highlighting selected follow-up record information.
7. The lung cancer patient follow-up system according to claim 1, further comprising a filtering display module for screening information of the target patient to be displayed.
8. The lung cancer patient follow-up system according to claim 1, further comprising a statistic module for counting the proportion of male and female patients in the system and the number of newly added patients per month.
9. The lung cancer patient follow-up system according to claim 1, further comprising a login module for providing a login and registration service for a user.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010437517.2A CN111627506A (en) | 2020-05-21 | 2020-05-21 | Lung cancer patient follow-up system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010437517.2A CN111627506A (en) | 2020-05-21 | 2020-05-21 | Lung cancer patient follow-up system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111627506A true CN111627506A (en) | 2020-09-04 |
Family
ID=72272532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010437517.2A Pending CN111627506A (en) | 2020-05-21 | 2020-05-21 | Lung cancer patient follow-up system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111627506A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040153343A1 (en) * | 2003-01-31 | 2004-08-05 | Phyllis Gotlib | Medical information query system |
| US20120109686A1 (en) * | 2010-11-01 | 2012-05-03 | Oxbow Intellectual Property, LLC | Electronic medical record system and method |
| CN110223745A (en) * | 2019-06-18 | 2019-09-10 | 吉林大学第一医院 | A kind of patients with lung cancer follow-up system |
| CN110415777A (en) * | 2019-08-01 | 2019-11-05 | 上海市第六人民医院 | A kind of rheumatoid arthritis patients electronics follow-up system |
-
2020
- 2020-05-21 CN CN202010437517.2A patent/CN111627506A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040153343A1 (en) * | 2003-01-31 | 2004-08-05 | Phyllis Gotlib | Medical information query system |
| US20120109686A1 (en) * | 2010-11-01 | 2012-05-03 | Oxbow Intellectual Property, LLC | Electronic medical record system and method |
| CN110223745A (en) * | 2019-06-18 | 2019-09-10 | 吉林大学第一医院 | A kind of patients with lung cancer follow-up system |
| CN110415777A (en) * | 2019-08-01 | 2019-11-05 | 上海市第六人民医院 | A kind of rheumatoid arthritis patients electronics follow-up system |
Non-Patent Citations (2)
| Title |
|---|
| 李沐华;周志鹏;: "基于ASP.NET的肺癌患者信息管理系统的设计与实现" * |
| 靳毅;刘巍;: "非小细胞肺癌患者数据库的设计与建立" * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mailis‐Gagnon et al. | Spinal cord stimulation for chronic pain | |
| Hamel et al. | Patient age and decisions to withhold life-sustaining treatments from seriously ill, hospitalized adults | |
| US20170364639A1 (en) | Automated assertion reuse for improved record linkage in distributed & autonomous healthcare environments with heterogeneous trust models | |
| US20180068075A1 (en) | Medical system and program | |
| Von Gunten et al. | Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time | |
| US8706529B2 (en) | Managing related electronic medical records | |
| Harvey et al. | Factor structure of cognition and functional capacity in two studies of schizophrenia and bipolar disorder: Implications for genomic studies. | |
| WO2009010948A1 (en) | Method and system for use of a database of personal data records | |
| Carrato et al. | Clinical management patterns and treatment outcomes in patients with non-small cell lung cancer (NSCLC) across Europe: EPICLIN-Lung study | |
| TWI605413B (en) | System and method for automated determination of the relative effectiveness of anti-cancer drug candidates | |
| Soukup et al. | A measure of case complexity for streamlining workflow in multidisciplinary tumor boards: mixed methods development and early validation of the MeDiC tool | |
| Chen et al. | Diagnostic yield of computed tomography scan for pediatric hearing loss: a systematic review | |
| Hallet et al. | Patterns of symptoms burden in neuroendocrine tumors: a population‐based analysis of prospective patient‐reported outcomes | |
| McWilliams et al. | Geographic variation in cancer-related imaging: Veterans Affairs health care system versus Medicare | |
| Kruse et al. | Do independent treatment centers offer more value than general hospitals? The case of cataract care | |
| CN111627506A (en) | Lung cancer patient follow-up system | |
| CN116563038B (en) | Medical insurance fee control recommendation method, system and storage medium based on regional big data | |
| CN111785369B (en) | Diagnostic prediction method, related device, and readable storage medium | |
| Best et al. | Continued heroin use during methadone treatment: relationships between frequency of use and reasons reported for heroin use | |
| WO2020082796A1 (en) | Method, device and apparatus for processing medical visit information based on data analysis, and medium | |
| KR101484766B1 (en) | Apparatus and Method for Generating Electron Form in Medical Information System | |
| CN113723836A (en) | Endowment management method and system, computer equipment and storage medium | |
| US20200210453A1 (en) | Real time data tracking, analytics data warehousing, and front end reporting system | |
| CN109949940B (en) | Big data mining system based on diabetes database | |
| Obi | Pulmonary sarcoidosis: beyond restriction and forced vital capacity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200904 |
|
| RJ01 | Rejection of invention patent application after publication |